Results

Pfizer Inc.

08/12/2020 | Press release | Distributed by Public on 08/12/2020 05:11

Pfizer and BioNTech Announce Publication of Peer-Reviewed Data from Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate, BNT162b1, Against SARS-CoV-2 in Nature